The SurgiCAL ProtEomics Laboratory (SCALPEL) at National University of Singapore, together with our industry collaborators from Bruker Daltonics and Laboratory Science Solutions, are proud to have hosted the inaugural international Mass Spectrometry Imaging Symposium.

​

Held in September 2019, the aim of the symposium was to showcase the state of the art of Mass Spectrometry Imaging (MSI) in the clinical arena. Mass spectrometry imaging allows tissue to be directly probed at the molecular level while maintaining microscopic spatial distribution, good resolution and excellent reproducibility. This relatively new technology has already made a significant impact in translational science and with new protocols and solutions in the pipeline, it promises to continue to do so for years to come.

​

Crucial to its functionality is the clinical question, tissue handling and storage, sample preparation, data acquisition and bioinformatics. To this end, we organized this symposium with world authorities in the clinical and academic fields sharing their experience in this area.

​

During this Symposium, SCALPEL had signed a landmark research collaboration agreement with Bruker, giving us access to state of the art instruments and their vast network of application specialists.